Jeremy Hunt the UK Secretary of State for Health and Greg Clark UK Secretary of State for Business have written a letter to the Financial Times. In the letter, they offer assurance over the UK government’s plans for the regulation of medicines as the UK leaves the EU, stating that the UK is fully committed to continuing the close working relationship with our European partners.
They express that UK would like to find a way to continue to collaborate with the EU, in the interests of public health and safety and that they would want patients to be assured that their safety is protected through the strongest regulatory framework and sharing of data.
The letter outlines three principles that will help the UK develop a new regulatory system post Brexit, these are that
- Patients should not be disadvantaged
- Innovators should be able to get their products into the UK market as quickly and simply as possible
- The UK continues to play a leading role promoting public health
The letter describes how the Industrial Strategy we will build on the UK’s legacy as a leader in medical innovation and that the Medicines and Healthcare Products Regulatory Agency (MHRA) will work with innovators to ensure that new treatments can reach patients quickly. If the UK does not achieve its desired outcome in working closely with the European Medicines Agency, the Government will create a regulatory system that protects the best interests of patients and supports the UK life science industry seeking to license new medicines as quickly as possible, and certainly no more slowly than at present. They express that the UK fee pricing will be competitive with current levels.
In response to the letter Mike Thompson, ABPI Chief Executive desceibed the letter as “a welcome recognition that the future of medicines regulation is a key priority for the Government as we negotiate a new relationship with the EU. It also signals a readiness to take a pragmatic approach to Brexit negotiations that puts people’s health first. This is a great first step and we look forward to seeing more detail in the coming weeks and months.”